192 related articles for article (PubMed ID: 1581881)
1. Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes. Report of two cases and review of the literature.
Verhoef G; Meeus P; Stul M; Mecucci C; Cassiman JJ; Van Den Berghe H; Boogaerts M
Cancer Genet Cytogenet; 1992 Apr; 59(2):161-6. PubMed ID: 1581881
[TBL] [Abstract][Full Text] [Related]
2. p190bcr/abl rearrangement in myelodysplastic syndromes: two reports and review of the literature.
Lesesve JF; Troussard X; Bastard C; Hurst JP; Nouet D; Callat MP; Lenormand B; Piguet H; Flandrin G; Macintyre E
Br J Haematol; 1996 Nov; 95(2):372-5. PubMed ID: 8904895
[TBL] [Abstract][Full Text] [Related]
3. Molecular implications of Ph (+) myelodysplastic syndrome.
Toyama K; Ohyashiki K; Ohyashiki JH
Adv Exp Med Biol; 1988; 241():67-71. PubMed ID: 3066168
[TBL] [Abstract][Full Text] [Related]
4. ETS1 gene in myelodysplastic syndrome with chromosome change at 11q23.
Ohyashiki K; Ohyashiki JH; Tauchi T; Iwabuchi H; Iwabuchi A; Toyama K
Cancer Genet Cytogenet; 1990 Mar; 45(1):73-80. PubMed ID: 2302688
[TBL] [Abstract][Full Text] [Related]
5. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature.
Keung YK; Beaty M; Powell BL; Molnar I; Buss D; Pettenati M
Leuk Res; 2004 Jun; 28(6):579-86. PubMed ID: 15120934
[TBL] [Abstract][Full Text] [Related]
6. A novel translocation t(3;22)(q21;q11) involving 3q21 in myelodysplastic syndrome-derived overt leukemia with thrombocytosis.
Yamamoto K; Nagata K; Tsurukubo Y; Morishita K; Hamaguchi H
Leuk Res; 2000 May; 24(5):453-7. PubMed ID: 10785268
[TBL] [Abstract][Full Text] [Related]
7. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
Suciu S; Kuse R; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood chromosome aberrations in MDS.
White AD; Jacobs A
Cancer Genet Cytogenet; 1992 Apr; 59(2):167-72. PubMed ID: 1581882
[TBL] [Abstract][Full Text] [Related]
9. Philadelphia chromosome- positive myelodysplastic syndrome with single lineage dysplasia.
Kumar A; Tilak V; Arora D; Marisha ; Rahul ; Gautam D; Ali A
Cancer Genet; 2023 Aug; 276-277():12-16. PubMed ID: 37267684
[TBL] [Abstract][Full Text] [Related]
10. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
[TBL] [Abstract][Full Text] [Related]
11. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome.
Jotterand Bellomo M; Parlier V; Mühlematter D; Grob JP; Beris P
Cancer Genet Cytogenet; 1992 Apr; 59(2):138-60. PubMed ID: 1581880
[TBL] [Abstract][Full Text] [Related]
12. Mixed myelodysplastic and myeloproliferative syndromes.
Neuwirtová R; Mociková K; Musilová J; Jelínek J; Havlícek F; Michalová K; Adamkov M
Leuk Res; 1996 Sep; 20(9):717-26. PubMed ID: 8947580
[TBL] [Abstract][Full Text] [Related]
13. Chronic myeloid leukemia with variation of translocation at (Ph) [ins (22;9) (q11;q21q34)]: a case report.
Wang Z; Zen W; Meng F; Xin X; Luo L; Sun H; Zhou J; Huang L
Int J Clin Exp Pathol; 2015; 8(10):13707-10. PubMed ID: 26722598
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
Solé F; Prieto F; Badia L; Woessner S; Florensa L; Caballin MR; Coll MD; Besses C; Sans-Sabrafen J
Cancer Genet Cytogenet; 1992 Nov; 64(1):12-20. PubMed ID: 1458444
[TBL] [Abstract][Full Text] [Related]
15. Abrupt evolution of Philadelphia chromosome-positive acute myeloid leukemia in myelodysplastic syndrome.
Fukunaga A; Sakoda H; Iwamoto Y; Inano S; Sueki Y; Yanagida S; Arima N
Eur J Haematol; 2013 Mar; 90(3):245-9. PubMed ID: 23240925
[TBL] [Abstract][Full Text] [Related]
16. Dek-can rearrangement in translocation (6;9)(p23;q34).
Soekarman D; von Lindern M; van der Plas DC; Selleri L; Bartram CR; Martiat P; Culligan D; Padua RA; Hasper-Voogt KP; Hagemeijer A
Leukemia; 1992 Jun; 6(6):489-94. PubMed ID: 1602786
[TBL] [Abstract][Full Text] [Related]
17. Phenylbutazone-induced myelodysplastic syndrome with Philadelphia translocation.
Ohyashiki K; Ohyashiki JH; Raza A; Preisler HD; Sandberg AA
Cancer Genet Cytogenet; 1987 Jun; 26(2):213-6. PubMed ID: 3567875
[TBL] [Abstract][Full Text] [Related]
18. der(1)t(1;19)(p12;p11): a new nonrandom chromosomal abnormality in myelodysplastic syndrome.
Gill JI; Varela M; Tsien F; Krause JR
Cancer Genet Cytogenet; 1997 Apr; 94(2):85-7. PubMed ID: 9109932
[TBL] [Abstract][Full Text] [Related]
19.
Rahman K; Singh MK; Gupta R; Dutta S; Nityanand S
J Cancer Res Ther; 2020; 16(1):173-176. PubMed ID: 32362632
[TBL] [Abstract][Full Text] [Related]
20. [Late appearing Philadelphia chromosome as another clone in a patient with myelodysplastic syndrome harboring der(5;12)(q10;q10) at diagnosis].
Manabe M; Yoshii Y; Mukai S; Sakamoto E; Kanashima H; Nakao T; Kubo Y; Fukushima H; Inoue T; Yamane T; Teshima H
Rinsho Ketsueki; 2012 Jun; 53(6):618-22. PubMed ID: 22790637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
